122 related articles for article (PubMed ID: 10071033)
1. Prolonged survival of corneal allografts incubated in alloantibody fragments.
Gebhardt BM; Varnell ED; Kaufman HE
Transplantation; 1999 Feb; 67(4):594-9. PubMed ID: 10071033
[TBL] [Abstract][Full Text] [Related]
2. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
[TBL] [Abstract][Full Text] [Related]
3. Protection of corneal allografts by CTLA4-Ig.
Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
[TBL] [Abstract][Full Text] [Related]
4. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of alloantibodies or F(ab')2 and prednisone on murine split heart allograft survival.
Schilling W; Svehag SE
Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):325-32. PubMed ID: 785946
[TBL] [Abstract][Full Text] [Related]
6. Membrane distribution and adsorptive endocytosis by C3b receptors on human polymorphonuclear leukocytes.
Fearon DT; Kaneko I; Thomson GG
J Exp Med; 1981 Jun; 153(6):1615-28. PubMed ID: 7252422
[TBL] [Abstract][Full Text] [Related]
7. [CTLA4-Ig prevents corneal allograft rejection in mice].
Shi WY; Xie LX
Zhonghua Yan Ke Za Zhi; 2004 Oct; 40(10):696-700. PubMed ID: 16200862
[TBL] [Abstract][Full Text] [Related]
8. A quantitative comparison of whole antibody and F(ab')2 in kidney allograft enhancement.
Winearls CG; Fabre JW; Millard PR; Morris PJ
Transplantation; 1979 Jul; 28(1):36-9. PubMed ID: 377591
[TBL] [Abstract][Full Text] [Related]
9. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
[TBL] [Abstract][Full Text] [Related]
10. Are corneal cells susceptible to antibody-mediated killing in corneal allograft rejection?
Hargrave SL; Mayhew E; Hegde S; Niederkorn J
Transpl Immunol; 2003; 11(1):79-89. PubMed ID: 12727479
[TBL] [Abstract][Full Text] [Related]
11. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
12. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
Hirsch R; Bluestone JA; DeNenno L; Gress RE
Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740
[TBL] [Abstract][Full Text] [Related]
15. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
[TBL] [Abstract][Full Text] [Related]
16. Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.
de Waal RM; Cornelissen IM; Capel PJ; Koene RA
J Immunol; 1979 Sep; 123(3):1353-5. PubMed ID: 469254
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HLA antibody cytotoxicity by intravenous immunoglobulin G F(ab')2 dimers, monomers, and monovalent F(ab).
Mahoney RJ; Breggia AE
Hum Immunol; 1999 Jun; 60(6):492-9. PubMed ID: 10408798
[TBL] [Abstract][Full Text] [Related]
19. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins.
Geltner D; Franklin EC; Frangione B
J Immunol; 1980 Oct; 125(4):1530-5. PubMed ID: 6774023
[TBL] [Abstract][Full Text] [Related]
20. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
